Clinical worsening also occurred less frequently with treprostinil ...

DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...

The complex and redundant biology underlying fibrosis is widely believed to contribute to the limited effectiveness of single-target approaches. “Fibrosis is a biologically complex, organ-specific ...

Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population. There is growing global interest in PF, evident from a nearly threefold ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming ...

The pooled global incidence and prevalence of progressive pulmonary fibrosis appear higher in the US than in Europe and South Korea.

Travis Corbitt knew he wasn't in the best shape, but he didn't understand why he felt like he could never catch his breath. He had been a police officer for more than 40 years, but chasing down ...

BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to ...

Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its approval.

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...